Open Access

Anticoagulation in Transcatheter Aortic Valve Implantation in Patients with Atrial Fibrillation: Results from ENVISAGE-TAVI AF trial.

Event: ESC Congress 2021 - The Digital Experience
Topic: Atrial Fibrillation (AF)
Session type: Satellite Symposium
Sponsored by Daiichi Sankyo Europe GmbH
Date: 30 August 2021
Time: 15:00 - 15:30

Congress Session

This content is currently on OPEN ACCESS

Sign in to view the resources

4 presentations in this session

Welcome and introduction.

Speaker: Doctor S. Saito (Kamakura, JP)

Edoxaban in patients with AF following TAVI: ENVISAGE-TAVI AF trial results.

Speaker: Professor N. van Mieghem (Rotterdam, NL)

New developments in NOACs and TAVI: How do we apply them in clinical practice?

Speaker: Professor D. Capodanno (Catania, IT)

Panel discussion.


3 speakers from this session

Doctor Shigeru Saito

Shonan Kamakura General Hospital, Kamakura (Japan)
2 presentations
0 follower

Professor Nicolas van Mieghem

Erasmus University Medical Centre, Rotterdam (Netherlands (The))
13 presentations

Professor Davide Capodanno

University of Catania, Catania (Italy)
27 presentations

Related content

ESC Premium Access

ESC Guidelines 2021 - Pacing and Resynchronisation

4 December 2021

ESC Premium Access

Update on endocarditis in 2021

3 December 2021

This platform is supported by

logo Novo Nordisk